No Prostate Cancer Survival Benefit With More Extensive Lymph Node Assessment

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — WASHINGTON — Extended pelvic lymph node dissection (ePLND) after radical prostatectomy failed to improve survival in intermediate- and high-risk prostate cancer compared with standard lymphadenectomy, long-term follow-up in a randomized study…




